# MGT Capital Investments, Inc.: financial statements, quarterly

MGTI · OTC · CIK 1001601 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mgti.md) · [Financials](/companies/mgti/financials.md) · [Filings](/companies/mgti/filings.md) · [Insiders](/companies/mgti/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mgti/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [107](/filings/0001493152-25-004358.md) | [98.0](/filings/0001641172-25-015412.md) | [92.0](/filings/0001641172-25-016942.md) | [102 d](/filings/0001493152-25-021523.md) | [102](/filings/0001493152-25-026013.md) | [88.0](/filings/0001493152-25-026341.md) | [62.0](/filings/0001641172-25-016942.md) | [70.0 d](/filings/0001493152-26-010453.md) | [87.0](/filings/0001493152-26-021724.md) | [0.0 d](/filings/0001493152-26-036523.md) | not reported | not reported |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(510)](/filings/0001493152-25-004358.md) | [(267)](/filings/0001641172-25-015412.md) | [(292)](/filings/0001641172-25-016942.md) | [(364) d](/filings/0001493152-25-021523.md) | [(227)](/filings/0001493152-25-026013.md) | [(335)](/filings/0001493152-25-026341.md) | [(293)](/filings/0001641172-25-016942.md) | [(269) d](/filings/0001493152-26-010453.md) | [(164)](/filings/0001493152-26-021724.md) | [(187)](/filings/0001493152-26-036523.md) | [(152)](/filings/0001493152-26-021724.md) | [(149)](/filings/0001493152-26-036523.md) |
| Interest expense | $k | [23.0](/filings/0001493152-23-017438.md) | [22.0](/filings/0001493152-23-040399.md) | [23.0](/filings/0001493152-23-044665.md) | [23.0 d](/filings/0001493152-24-014891.md) | [24.0](/filings/0001493152-25-026013.md) | [27.0](/filings/0001493152-25-026341.md) | [32.0](/filings/0001641172-25-016942.md) | [220 d](/filings/0001493152-26-010453.md) | [50.0](/filings/0001493152-26-021724.md) | [43.0](/filings/0001493152-26-036523.md) | [25.0](/filings/0001493152-26-021724.md) | [24.0](/filings/0001493152-26-036523.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(3,798)](/filings/0001641172-25-016942.md) | [2,418](/filings/0001641172-25-016942.md) | [701](/filings/0001641172-25-016942.md) | [(5,454) d](/filings/0001493152-25-021523.md) | [296](/filings/0001493152-25-026341.md) | [5,272](/filings/0001493152-25-026341.md) | [404](/filings/0001641172-25-016942.md) | [(451) d](/filings/0001493152-26-010453.md) | [(214)](/filings/0001493152-26-036523.md) | [446](/filings/0001493152-26-036523.md) | [(183)](/filings/0001493152-26-036523.md) | [(2,773)](/filings/0001493152-26-036523.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001493152-25-004358.md) | [0.00](/filings/0001641172-25-015412.md) | [0.00](/filings/0001641172-25-016942.md) | not reported | [0.00](/filings/0001493152-25-026013.md) | [0.01](/filings/0001493152-25-026341.md) | [0.00](/filings/0001641172-25-016942.md) | not reported | [0.00](/filings/0001493152-26-021724.md) | [0.00](/filings/0001493152-26-036523.md) | [0.00](/filings/0001493152-26-021724.md) | [0.00](/filings/0001493152-26-036523.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001493152-25-004358.md) | [0.00](/filings/0001641172-25-015412.md) | [0.00](/filings/0001641172-25-016942.md) | not reported | [0.00](/filings/0001493152-25-026013.md) | [0.01](/filings/0001493152-25-026341.md) | [0.00](/filings/0001641172-25-016942.md) | not reported | [0.00](/filings/0001493152-26-021724.md) | [0.00](/filings/0001493152-26-036523.md) | [0.00](/filings/0001493152-26-021724.md) | [0.00](/filings/0001493152-26-036523.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | [295](/filings/0001493152-23-040399.md) | [274](/filings/0001493152-23-044665.md) | [8.0](/filings/0001493152-25-021523.md) | [26.0](/filings/0001493152-25-004358.md) | [3.0](/filings/0001641172-25-015412.md) | [0.0](/filings/0001641172-25-016942.md) | [6.0](/filings/0001493152-26-010453.md) | [1.0](/filings/0001493152-25-026013.md) | [254](/filings/0001493152-25-026341.md) | [103](/filings/0001493152-26-036523.md) | [218](/filings/0001493152-26-021724.md) | [232](/filings/0001493152-26-036523.md) |
| Current assets | $k | [336](/filings/0001493152-23-040399.md) | [309](/filings/0001493152-23-044665.md) | [25.0](/filings/0001493152-25-021523.md) | [40.0](/filings/0001493152-25-004358.md) | [46.0](/filings/0001641172-25-015412.md) | [44.0](/filings/0001641172-25-016942.md) | [51.0](/filings/0001493152-26-010453.md) | [5.0](/filings/0001493152-25-026013.md) | [258](/filings/0001493152-25-026341.md) | [106](/filings/0001493152-26-036523.md) | [224](/filings/0001493152-26-021724.md) | [232](/filings/0001493152-26-036523.md) |
| Total assets | $k | [1,380](/filings/0001493152-23-040399.md) | [1,284](/filings/0001493152-23-044665.md) | [932](/filings/0001493152-25-021523.md) | [892](/filings/0001493152-25-004358.md) | [849](/filings/0001641172-25-015412.md) | [798](/filings/0001641172-25-016942.md) | [764](/filings/0001493152-26-010453.md) | [689](/filings/0001493152-25-026013.md) | [258](/filings/0001493152-25-026341.md) | [106](/filings/0001493152-26-036523.md) | [224](/filings/0001493152-26-021724.md) | [232](/filings/0001493152-26-036523.md) |
| Current liabilities | $k | [5,737](/filings/0001493152-23-040399.md) | [4,611](/filings/0001493152-23-044665.md) | [9,770](/filings/0001493152-25-021523.md) | [9,016](/filings/0001493152-25-004358.md) | [3,443](/filings/0001641172-25-015412.md) | [2,988](/filings/0001641172-25-016942.md) | [3,252](/filings/0001493152-26-010453.md) | [3,391](/filings/0001493152-25-026013.md) | [2,514](/filings/0001493152-25-026341.md) | [1,211](/filings/0001493152-26-036523.md) | [1,131](/filings/0001493152-26-021724.md) | [693](/filings/0001493152-26-036523.md) |
| Total liabilities | $k | [6,074](/filings/0001493152-23-040399.md) | [4,924](/filings/0001493152-23-044665.md) | [9,790](/filings/0001493152-25-021523.md) | [9,016](/filings/0001493152-25-004358.md) | [3,443](/filings/0001641172-25-015412.md) | [2,988](/filings/0001641172-25-016942.md) | [3,252](/filings/0001493152-26-010453.md) | [3,391](/filings/0001493152-25-026013.md) | [2,514](/filings/0001493152-25-026341.md) | [2,387](/filings/0001493152-26-036523.md) | [2,312](/filings/0001493152-26-021724.md) | [693](/filings/0001493152-26-036523.md) |
| Long-term debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $k | [(4,694)](/filings/0001641172-25-016942.md) | [(3,640)](/filings/0001641172-25-016942.md) | [(8,858)](/filings/0001493152-26-010453.md) | [(8,124)](/filings/0001493152-25-026341.md) | [(2,594)](/filings/0001493152-25-026341.md) | [(2,190)](/filings/0001641172-25-016942.md) | [(2,488)](/filings/0001493152-26-036523.md) | [(2,702)](/filings/0001493152-26-036523.md) | [(2,256)](/filings/0001493152-26-036523.md) | [(2,281)](/filings/0001493152-26-036523.md) | [(2,088)](/filings/0001493152-26-036523.md) | [(461)](/filings/0001493152-26-036523.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(21.0)](/filings/0001493152-25-004358.md) | [(122) d](/filings/0001641172-25-015412.md) | [(161) d](/filings/0001641172-25-016942.md) | [(406) d](/filings/0001493152-25-021523.md) | [(177)](/filings/0001493152-25-026013.md) | [(173) d](/filings/0001493152-25-026341.md) | [(122) d](/filings/0001641172-25-016942.md) | [(75.0) d](/filings/0001493152-26-010453.md) | [(131)](/filings/0001493152-26-021724.md) | [(409) d](/filings/0001493152-26-036523.md) | [(260)](/filings/0001493152-26-021724.md) | [(271) d](/filings/0001493152-26-036523.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [648](/filings/0001493152-23-040399.md) | [678](/filings/0001493152-23-044665.md) | [720](/filings/0001493152-25-004358.md) | [734](/filings/0001641172-25-015412.md) | [783](/filings/0001641172-25-016942.md) | [908](/filings/0001493152-25-026013.md) | [1,021](/filings/0001493152-25-026341.md) | [1,141](/filings/0001641172-25-016942.md) | [2,491](/filings/0001493152-26-021724.md) | [3,141](/filings/0001493152-26-036523.md) | [4,954](/filings/0001493152-26-021724.md) | [5,195](/filings/0001493152-26-036523.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,290,802,029 at 2026-08-06, from the cover of the [10-Q filed 2026-08-07](/filings/0001493152-26-036523.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.